Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Axel Hauschild"'
Autor:
Sally H. Ibbotson, R. Aschoff, Hans-Joachim Schulze, Hermann Lübbert, R. Dominicus, H.M. Ockenfels, R.-M. Szeimies, Axel Hauschild, Uwe Reinhold, P. Radny, Beate Schmitz, H. Stege, G. Gupta, Carola Berking, D. Gröne, Hjalmar Kurzen, Petra Staubach, F. Hübinger, S. Ekanayake-Bohlig, R. Ostendorf, Martina Ulrich, Colin A. Morton, V. Jasnoch, A. Gertzmann, I. Ziabreva, Thomas Dirschka, S. Keohane, M. Sebastian
Publikováno v:
British Journal of Dermatology.
Background: Basal cell carcinoma (BCC) represents the most common nonmelanoma skin cancer worldwide, affecting mainly adult, fair-skinned individuals. The World Health Organization distinguishes aggressive and nonaggressive forms, of which prototypic
Autor:
Fei Su, Matthew J. Klimek, Axel Hauschild, Caroline Robert, Christopher McCormack, Victor G. Prieto, Caroline C. Kim, Olivia Spleiss, Andrew K. Joe, K. B. Nolop, Kerstin Trunzer, James L. Troy, Madeleine Duvic, Joseph F. Grippo, Patricia L. Myskowski, Dirk Schadendorf, B. Nelson, Mario E. Lacouture, Richard J. Lee
Publikováno v:
The Oncologist. 18:314-322
Background. Vemurafenib has been approved for the treatment of patients with advanced BRAFV600E-mutant melanoma. This report by the Vemurafenib Dermatology Working Group presents the characteristics of dermatologic adverse events (AEs) that occur in
Autor:
Alexander Katalinic, Nora Eisemann, Bernd Holleczek, Axel Hauschild, Sabine Luttmann, Annika Waldmann, Lina Jansen, Katharina Emrich, Hermann Brenner
Publikováno v:
British Journal of Dermatology. 167:606-612
Summary Background Prior analyses of survival of patients with primary cutaneous malignant melanoma from Germany were based only on small populations and need to be updated. Objectives We give a detailed overview of relative 5-year survival by sex, a
Publikováno v:
British Journal of Dermatology. 170:220-222
Autor:
Georg Popp, Rolf-Markus Szeimies, R. Dominicus, F. Borrosch, Axel Hauschild, M. Stocker, C. Ortland, Uwe Reinhold, Eggert Stockfleth, H. Brüning, H. Mensing, M. Brunnert, A.C.E. Moor, Kristian Reich
Publikováno v:
British Journal of Dermatology. 162:410-414
Summary Background Photodynamic therapy with a self-adhesive 5-aminolaevulinic acid (5-ALA) patch shows high efficacy rates in the treatment of mild to moderate actinic keratosis (AK) in short term trials. Objectives The purpose of the trial was to f
Autor:
Axel Hauschild, Shenhong Wu, Laura S. Wood, Roger T. Anderson, Joan Guitart, Caroline Robert, Claus Garbe, Igor Puzanov, Janice P. Dutcher, Michael B. Atkins, Doru T Alexandrescu, Mario E. Lacouture, Heidi H. Kong
Publikováno v:
The Oncologist. 13:1001-1011
The multitargeted kinase inhibitors (MKIs) sorafenib and sunitinib have shown benefit in patients with renal cell carcinoma, hepatocellular carcinoma (sorafenib), and gastrointestinal stromal tumor (sunitinib). Their efficacy in other malignancies is
Publikováno v:
British Journal of Dermatology. 147:150-153
We report an 80-year-old man suffering from an angiosarcoma of the scalp. Because of the wide extent of the lesions, surgery was not performed. Instead, the patient was treated with electron-beam radiation. Later, the patient failed to benefit from r
Autor:
Axel Hauschild
Publikováno v:
British Journal of Dermatology. 166:3-5
Publikováno v:
British Journal of Dermatology. 140:1065-1071
In the immunohistology of malignant melanoma the use of polyclonal antibodies against protein S100 is well established. Recently, it was shown that S100B, a subunit of the S100 protein family, is detectable in the serum of melanoma patients and corre
Publikováno v:
Clinical and Experimental Dermatology. 28:31-33
We describe a 50-year-old female patient who developed extensive lymphomatous infiltrates on her forehead, scalp and face within a few months. Histology and immunohistochemistry of skin tumours revealed a CD20 positive follicular B-cell lymphoma. Sub